These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8614508)

  • 41. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.
    Pels H; Juergens A; Glasmacher A; Schulz H; Engert A; Linnebank M; Schackert G; Reichmann H; Kroschinsky F; Vogt-Schaden M; Egerer G; Bode U; Schaller C; Lamprecht M; Hau P; Deckert M; Fimmers R; Bangard C; Schmidt-Wolf IG; Schlegel U
    J Neurooncol; 2009 Feb; 91(3):299-305. PubMed ID: 18931887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.
    Schlegel U; Pels H; Glasmacher A; Kleinschmidt R; Schmidt-Wolf I; Helmstaedter C; Fliessbach K; Deckert M; Van Roost D; Fimmers R; Bode U; Klockgether T
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):118-22. PubMed ID: 11413277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
    Fisher B; Seiferheld W; Schultz C; DeAngelis L; Nelson D; Schold SC; Curran W; Mehta M
    J Neurooncol; 2005 Sep; 74(2):201-5. PubMed ID: 16193393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
    Kim YR; Kim SH; Chang JH; Suh CO; Kim SJ; Kim Y; Hwang DY; Jang JE; Hyun SY; Cheong JW; Min YH; Kim JS
    Ann Hematol; 2014 Feb; 93(2):211-9. PubMed ID: 23903866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS.
    Forsyth PA; Yahalom J; DeAngelis LM
    Neurology; 1994 Aug; 44(8):1473-9. PubMed ID: 8058152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.
    Welch MR; Omuro A; Deangelis LM
    Neuro Oncol; 2012 Oct; 14(10):1304-11. PubMed ID: 22952196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma.
    Gerard LM; Imrie KR; Mangel J; Buckstein R; Doherty M; Mackenzie R; Cheung MC
    Leuk Lymphoma; 2011 Oct; 52(10):1882-90. PubMed ID: 21663504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of new-onset primary central nervous system lymphoma in elderly patients using RMPV chemotherapy: a single-institution experience.
    Yoshida M; Kato T; Hiu T; Imaizumi Y; Morimoto S; Niino D; Yamaguchi S; Baba S; Ujifuku K; Yoshida K; Matsuo A; Morofuji Y; Izumo T; Okano S; Miyazaki Y; Matsuo T
    Int J Hematol; 2023 Sep; 118(3):333-339. PubMed ID: 37393325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
    Gaynor ER; Ultmann JE; Golomb HM; Sweet DL
    J Clin Oncol; 1985 Dec; 3(12):1596-604. PubMed ID: 3877790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB
    Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical study of primary central nervous system lymphoma: the role of chemotherapy].
    Maeda Y; Matsumoto K; Kuriyama M; Ono Y; Kunishio K; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1997 May; 24(7):807-13. PubMed ID: 9170518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
    Sun X; Liu J; Wang Y; Bai X; Chen Y; Qian J; Zhu H; Liu F; Qiu X; Sun S; Ji N; Liu Y
    Oncotarget; 2017 Jul; 8(30):49156-49164. PubMed ID: 28467782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
    Pels H; Deckert-Schlüter M; Glasmacher A; Kleinschmidt R; Oehring R; Fischer HP; Bode U; Schlegel U
    Hematol Oncol; 2000 Mar; 18(1):21-32. PubMed ID: 10797527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
    Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
    Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.
    Soussain C; Merle-Béral H; Reux I; Sutton L; Fardeau C; Gerber S; Ben Othman T; Binet JL; Lehoang P; Leblond V
    Leuk Lymphoma; 1996 Oct; 23(3-4):339-45. PubMed ID: 9031115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.
    Hattori K; Sakata-Yanagimoto M; Okoshi Y; Kato T; Kurita N; Yokoyama Y; Obara N; Takano S; Ishikawa E; Yamamoto T; Matsumura A; Hasegawa Y; Chiba S
    J Clin Exp Hematop; 2017 Oct; 57(2):41-46. PubMed ID: 28781291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment Options for Recurrent Primary CNS Lymphoma.
    Kaulen LD; Baehring JM
    Curr Treat Options Oncol; 2022 Nov; 23(11):1548-1565. PubMed ID: 36205806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.